Market Cap 12.29B
Revenue (ttm) 1.52B
Net Income (ttm) 251.85M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 16.60%
Debt to Equity Ratio 0.00
Volume 5,280
Avg Vol 6,350
Day's Range N/A - N/A
Shares Out 130.80M
Stochastic %K 63%
Beta 0.91
Analysts Strong Sell
Price Target N/A

Company Profile

Cochlear Limited provides implantable hearing solutions for children and adults worldwide. The company offers cochlear implant systems, sound processor upgrades, bone conduction systems, and other products. It also provides cochlear nucleus systems, including Nucleus sound processors, smart bimodal hearing solution, and Nucleus implants; cochlear Baha systems comprising Baha 6 max sound processor and Baha implant; and accessories, such as wireless devices and Nucleus water-safe accessories. The...

Industry: Medical Devices
Sector: Healthcare
Phone: 61 2 9428 6555
Fax: 61 2 9428 6353
Address:
1 University Avenue, Macquarie University, Sydney, Australia
Latest News on CHEOY
No data available.